Identification and in vivo Efficacy Assessment of Approved Orally Bioavailable Human Host Protein-Targeting Drugs With Broad Anti-influenza A Activity-Reference-Cited by-同舟云学术

Identification and in vivo Efficacy Assessment of Approved Orally Bioavailable Human Host Protein-Targeting Drugs With Broad Anti-influenza A Activity

Published:2019-06-05 Issue: Volume:10 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Enkirch Theresa,Sauber Svenja,Anderson Danielle E.,Gan Esther S.,Kenanov Dimitar,Maurer-Stroh Sebastian,von Messling Veronika

Funder

Deutsches Zentrum für Infektionsforschung

Bundesministerium für Gesundheit

Ministry of Health -Singapore

Agency for Science, Technology and Research

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference61 articles.

1. Influenza pandemics of the 20th century;Kilbourne,2006

2. Why should influenza be a public health priority;Osterhaus,2015

3. Orthomyxoviridae;Shaw,2013

4. Unusual influenza A viruses in bats;Mehle,2014

5. Transmission of influenza A viruses;Neumann,2015

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Computational repurposing of drugs for viral diseases and current and future pandemics;Journal of Mathematical Chemistry;2024-02-05

2. Identification of genetic biomarkers, drug targets and agents for respiratory diseases utilising integrated bioinformatics approaches;Scientific Reports;2023-11-04

3. Identifying repurposed drugs with moderate anti-influenza virus activity through computational prioritization of drug-target pairs;2023-08-02

4. Metallo-antiviral aspirants: Answer to the upcoming virus outbreak;European Journal of Medicinal Chemistry Reports;2023-08

5. Development of Gallium(III) as an Antimicrobial Drug Targeting Pathophysiologic Iron Metabolism of Human Pathogens;ACS Infectious Diseases;2023-03-30